Dharti Proteins receives BSE listing approval for 5,00,000 shares

Dharti Proteins Ltd has received listing approval from BSE Limited for 5,00,000 equity shares of ₹10 each. This allotment was made pursuant to an approved resolution plan by the NCLT, Ahmedabad Bench, dated November 18, 2025. The shares include 25,000 allotted due to capital reduction and 4,75,000 shares, of which 4,25,000 were allotted to the Successful Resolution Applicant (Promoter Group) and 50,000 to a Secured Financial Creditor on a preferential basis. The company is now processing corporate actions with NSDL and CDSL and will apply for trading approval soon.